(Allergan plc)

	AGN latest price $266.5396 (2.67%) ($256.2606 - $268.1901) on Thu. Oct. 8, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.56% (three month average)
RSI	42
Latest Price	$266.5396(2.67%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.4% a day on average for past five trading days.
Weekly Trend	AGN declines -1.9% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(52%)    IBB(51%)    XBI(45%)    ARKG(41%)    SPY(41%)
Factors Impacting AGN price	AGN will decline at least -1.28% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-8%)    SHY(-6%)    GLD(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.28% (StdDev 2.56%)
Hourly BBV	0 ()
Intraday Trend	2.8%

Resistance Level	$273.04
5 Day Moving Average	$267.28(-0.28%)
10 Day Moving Average	$263.2(1.27%)
20 Day Moving Average	$273.04(-2.38%)
To recent high	-18.7%
To recent low	9.5%
Market Cap	$87.878b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed